PRESS RELEASE published on 07/13/2023 at 19:29, 1 year 4 months ago Kuros Biosciences Announces Completion of Enrollment in the Fibrin-PTH Phase 2 Trial
PRESS RELEASE published on 05/08/2023 at 17:18, 1 year 6 months ago Annual General Meeting of Kuros Biosciences approves all resolutions
PRESS RELEASE published on 04/27/2023 at 07:00, 1 year 6 months ago Kuros reports 168% increase in direct MagnetOs sales in the first quarter of 2023
PRESS RELEASE published on 03/15/2023 at 07:00, 1 year 8 months ago Kuros Biosciences reports results for the full year 2022
PRESS RELEASE published on 02/21/2023 at 07:00, 1 year 9 months ago Kuros Biosciences Announces Publication of Supportive Osteoimmunology Data for MagnetOs Bone Graft
PRESS RELEASE published on 02/16/2023 at 18:01, 1 year 9 months ago Kuros Biosciences Announces Changes to Executive Management Team
Published on 11/21/2024 at 14:15, 20 minutes ago neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 35 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 35 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 35 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:16, 19 minutes ago EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 20 minutes ago ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 12:35, 2 hours ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 06:58, 7 hours 37 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 15 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 50 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 50 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
